Cellomics: Andy Liu
Cellomics has appointed Andy Liu group CEO of the company. He was previously president of data security and privacy firm Basebit Technology as well as president of Asia Pacific and China for life sciences analytics and clinical research firm Iqvia. He also worked at Merck and UCB Pharma. Based in Hong Kong, Cellomics develops liquid biopsy tests for cancer screening, precision diagnosis, and disease monitoring leveraging circulating tumor cell-based technology, as well as PCR- and next-generations sequencing-based technology.